Science in Action services

We work according to current ICH-GCP requirements, all applicable local and global laws and guidelines.

SCOPUS is a Clinical Arm of “Science in Action” research organization that offers a broad range of clinical development services in all stages and aspects of study design. Our scientific background and “hands on” experience to design, develop and execute early as well as advanced clinical development programs allow you to increase efficiencies, reduce timelines and costs and to realize the full potential and value of your product. Our service packages are flexible and agile and perfectly tailored to your needs. Scopus global infrastructure and support allow us to collaborate with opinion leaders and to conduct clinical trials across EU (Eastern and Western), US, Latin America, China and Hong Kong.

Our clients and partners include medical device, pharmaceutical and biotechnology organizations. We help to accelerate the process of bringing your new product to market with the experience, resources and global reach of SCOPUS team.

SIA encourages the development of new drugs from preliminary idea phase. SIA offers partnership and conducts preclinical R&D needed for concept evaluation and initial validation. To this end, SIA conducts research internally and in collaboration with other researchers.

SIA`s philanthropic research supports the Israeli Duchenne Parent Association. This is an eort to develop a cure for Duchenne Muscular Dystrophy (DMD). DMD is the most common, fatal genetic disorder diagnosed in childhood. It aects approximately 1 in every 3,500 male infants born. We invite you to read more about SIA’s Philanthropic DMD Research and Duchenne Animal Models.

Project phase:; Medical devices: First in Human (FIH), pivotal studies. Pharmaceuticals: FIH, Phase I-IV.

In vitro migration and invasion assays provide a simple and fast quantitative platform to measure cellular migratory or invasive phenotypes, in vitro. In this assay, cells are allowed to migrate through an artificial membrane towards a chemo-attractant gradient. The efficiency of this process is assessed by fluorometric analysis. Migration through a membrane coated with basement membrane components provides a model system to study invasive potential of the cell culture.